Friday, May 1, 2026

Trump’s Call for Rehearing: What Does It Mean for U.S. Tariffs and Trade?

Trump criticizes the Supreme Court's tariff ruling, urging a rehearing to prevent potential refunds to exploitative corporations.

North Korea Eyes Sports Dominance with Major Leadership Shifts in National Committee

North Korea expands sports initiatives post-COVID, appointing new officials and focusing on upcoming international events.

North Korea, National Defense·Construction Performance Self-Praise, Diplomacy Performance “Silence”… Tightly Hidden External Policy Stance

North Korea celebrates 2025 as a historic year under Kim Jong Un, focusing on defense and construction while omitting diplomatic efforts.

Tag: Growth

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Angel Robotics blurs line between healthcare and industry with wearable robots

Angel Robotics is enhancing rehabilitation and industrial safety with wearable robots, targeting gait assistance and reducing musculoskeletal disorders.

Coreline Soft’s SaaS Shift: How AI is Transforming Medical Imaging in Europe and Asia

Coreline Soft shifts to a SaaS model, expanding into the European market, enhancing revenue stability, and focusing on policy integration.

D&D Pharmatech signs $1.24 million obesity drug research deal with Pfizer

D&D Pharmatech partners with Pfizer for a $1.24M obesity treatment project, marking a significant revenue milestone for the company.

2026 PRP Kit Revolution: How Humedix and Medisarang Are Transforming Regenerative Medicine

Humedics and Medisarang partner to develop regenerative medicine devices, focusing on PRP kits for aesthetics and other medical fields.

Truxima: How the First Korean Biosimilar Achieved 35.8% Market Share in the U.S.!

Celltrion’s Truxima becomes South Korea's first biosimilar to lead U.S. prescription market, boosted by tariff exemptions and strong growth.

How Dr. Ville is Revolutionizing Medical Knowledge Sharing for 40,000+ Doctors in 2026

Dr. Ville expands as a physician platform, offering relevant content and support, surpassing 40,000 members with significant growth in engagement.

Stoboclo: How This New Osteoporosis Treatment Achieved 11.8 Billion KRW in Sales in Just One Year

Daewoong Pharmaceutical's Stoboclo, a biosimilar for osteoporosis, achieved 11.8 billion KRW in sales in its first year, marking rapid growth.

Drug Price Reform Plan Prompts Emergency Meeting by South Korean Pharma Group

The Korea Pharmaceutical and Bio-Pharma Association plans strategies to address the new drug price reform and improve the industry.

How Celltrion’s Local Production Strategy Eliminates U.S. Drug Tariffs Influence

Celltrion resolves tariff impacts on U.S. sales, boosting local production and growth opportunities for its biosimilars, including Zymfentra.

Boehringer Ingelheim’s People Promise: How HR Innovation is Shaping the Future of Work in Asia

Boehringer Ingelheim emphasizes a people-centered strategy, focusing on talent mobility, leadership development, and diversity in the Asia-Pacific region.

Samsung Biologics America Achieves Record Profit: What This Means for Global Expansion in 2026

Samsung Biologics America reports record profits, showcasing its successful global expansion strategy despite previous revenue dips.

Unlock YouTube Earnings: New 500 Subscriber Requirement for Shopping Program

YouTube lowers eligibility for its Partner Program to 500 subscribers, enabling creators to earn commissions from tagged products.

2026 Senior Care Market: CareLabs’ Bold New Venture Explained

CareLabs CEO Lee Min-kyung announces plans to enter the senior care market, leveraging digital healthcare for growth and innovation.

Lotte Biologics Wins CDMO Leadership Award… Validates “Quality Management”

Lotte Biologics wins "Best New or Relaunched CDMO" at the 2026 CDMO Leadership Awards, showcasing rapid growth and global recognition.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.